Lipid Based Anti-Retroviral Nanocarriers: A Review of Current Literature and Ongoing Studies

E-ISSN： 2210-304x|7|2|71-82

ISSN： 2210-3031

Source： Drug Delivery Letters, Vol.7, Iss.2, 2017-08, pp. : 71-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platform for Lipid Based Nanocarriers' Formulation Components and their Potential Effects: A Literature Review

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6613-6629

Bentham Science Publishers

Access to resources Recommend Favorite

Adherence to Anti-Retroviral Therapy and Its Determinants in HIV/AIDS Patients: A Review

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 12, Iss. 5, 2012-10 ,pp. : 346-356

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-Based Nanocarriers for RNA Delivery

Current Pharmaceutical Design, Vol. 21, Iss. 22, 2015-01 ,pp. : 3140-3147

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro and in vivo studies of lipid-based nanocarriers for oral N₃-o-toluyl-fluorouracil delivery

By Liu Chunxi Liu Donghua Bai Fan Zhang Jian Zhang Na

Drug Delivery, Vol. 17, Iss. 5, 2010-07 ,pp. : 352-363

Informa Healthcare

Access to resources Recommend Favorite

A Highlight on Lipid Based Nanocarriers for Transcutaneous Immunization

Current Pharmaceutical Biotechnology, Vol. 16, Iss. 4, 2015-04 ,pp. : 371-379

Bentham Science Publishers

Access to resources Recommend Favorite